South San Francisco, CA November 8, 2017 Tricida, Inc Press Release SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc., a Phase 3 stage biopharmaceutical company focused on the discovery and development of non-absorbed oral drug therapies, today announced the closing of an oversubscribed…